Description:Rabbit polyclonal antibody to CABC1Immunogen:KLH-conjugated synthetic peptide encompassing a sequence within the center region of human CABC1. The exact sequence is proprietary.Purification:The antibody was purified by immunogen affinity chromatography.Clonality:PolyclonalForm:Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.Dilution:WB (1/500 - 1/1000), IH (1/100 - 1/200), IF/IC (1/100 - 1/500)Gene Symbol:ADCK3Alternative Names:CABC1; Chaperone activity of bc1 complex-like mitochondrial; Chaperone-ABC1-like; aarF domain-containing protein kinase 3
Entrez Gene (Human):
56997;
Entrez Gene (Mouse):
67426;
Entrez Gene (Rat):
360887;
SwissProt (Human):
Q8NI60;
SwissProt (Mouse):
Q60936;
SwissProt (Rat):
Q5BJQ0;
Storage/Stability:Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Western blot analysis of CABC1 expression in HeLa (A), U251MG (B) whole cell lysates. (Predicted band size: 71 kD; Observed band size: 72 kD)
-
Immunohistochemical analysis of CABC1 staining in human brain formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
-
Immunofluorescent analysis of CABC1 staining in HeLa cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
Frontal-Subcortical Protein Expression following Prenatal Exposure to Maternal Inflammation